{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:28:38Z","timestamp":1792229318539,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":212,"publisher":"Springer New York","isbn-type":[{"value":"9781493966530","type":"print"},{"value":"9781493966554","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6655-4_1","type":"book-chapter","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T01:25:45Z","timestamp":1479777945000},"page":"1-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Current Trends and Alternative Scenarios in EBV Research"],"prefix":"10.1007","author":[{"given":"Janos","family":"Minarovits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Helmut","family":"Niller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1:702\u2013703","journal-title":"Lancet"},{"key":"1_CR2","doi-asserted-by":"publisher","unstructured":"Munz C (Ed) (2015) Epstein Barr virus volume 1: one herpes virus: many diseases. In: Current Topics in Microbiology and Immunology, vol 390. Springer International Publishing, New York. doi: 10.1007\/978-3-319-22822-8","DOI":"10.1007\/978-3-319-22822-8"},{"key":"1_CR3","doi-asserted-by":"publisher","unstructured":"Munz C (Ed) (2015) Epstein Barr virus volume 2: one herpes virus: many diseases. In: Current topics in microbiology and immunology, vol 391. Springer International Publishing, New York. doi: 10.1007\/978-3-319-22834-1","DOI":"10.1007\/978-3-319-22834-1"},{"issue":"5974","key":"1_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/310207a0","volume":"310","author":"R Baer","year":"1984","unstructured":"Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310(5974):207\u2013211","journal-title":"Nature"},{"issue":"2","key":"1_CR5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/JVI.02517-12","volume":"87","author":"Z Lin","year":"2013","unstructured":"Lin Z, Wang X, Strong MJ, Concha M, Baddoo M, Xu G, Baribault C, Fewell C, Hulme W, Hedges D, Taylor CM, Flemington EK (2013) Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains. J Virol 87(2):1172\u20131182. doi: 10.1128\/JVI.02517-12","journal-title":"J Virol"},{"issue":"18","key":"1_CR6","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1128\/JVI.01665-14","volume":"88","author":"H Kwok","year":"2014","unstructured":"Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK (2014) Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol 88(18):10662\u201310672. doi: 10.1128\/JVI.01665-14","journal-title":"J Virol"},{"issue":"10","key":"1_CR7","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1128\/JVI.03614-14","volume":"89","author":"AL Palser","year":"2015","unstructured":"Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P (2015) Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. J Virol 89(10):5222\u20135237. doi: 10.1128\/JVI.03614-14","journal-title":"J Virol"},{"issue":"Pt 1","key":"1_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-22822-8_4","volume":"390","author":"PJ Farrell","year":"2015","unstructured":"Farrell PJ (2015) Epstein-Barr virus strain variation. Curr Top Microbiol Immunol 390(Pt 1):45\u201369. doi: 10.1007\/978-3-319-22822-8_4","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"1_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.4459","volume":"235","author":"M Vockerodt","year":"2015","unstructured":"Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG (2015) The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol 235(2):312\u2013322. doi: 10.1002\/path.4459","journal-title":"J Pathol"},{"issue":"2","key":"1_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.4448","volume":"235","author":"SW Tsao","year":"2015","unstructured":"Tsao SW, Tsang CM, To KF, Lo KW (2015) The role of Epstein-Barr virus in epithelial malignancies. J Pathol 235(2):323\u2013333. doi: 10.1002\/path.4448","journal-title":"J Pathol"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-24738-0_3","volume":"879","author":"HH Niller","year":"2016","unstructured":"Niller HH, Banati F, Salamon D, Minarovits J (2016) Epigenetic alterations in Epstein-Barr virus-associated diseases. Adv Exp Med Biol 879:39\u201369. doi: 10.1007\/978-3-319-24738-0_3","journal-title":"Adv Exp Med Biol"},{"key":"1_CR12","first-page":"1898","volume-title":"Fields virology","author":"R Longnecker","year":"2013","unstructured":"Longnecker R, Kieff E, Cohen JI (2013) Epstein Barr virus. In: Knipe DM, Howley PM (eds) Fields virology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1898\u20131959","edition":"6"},{"issue":"1","key":"1_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1(1):75\u201382. doi: 10.1038\/35095584","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"1_CR14","first-page":"5584","volume":"60","author":"G Decaussin","year":"2000","unstructured":"Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, Ooka T (2000) Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 60(19):5584\u20135588","journal-title":"Cancer Res"},{"issue":"10","key":"1_CR15","first-page":"2745","volume":"60","author":"A zur Hausen","year":"2000","unstructured":"zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ (2000) Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 60(10):2745\u20132748","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jmv.20327","volume":"76","author":"E Seto","year":"2005","unstructured":"Seto E, Yang L, Middeldorp J, Sheen TS, Chen JY, Fukayama M, Eizuru Y, Ooka T, Takada K (2005) Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 76(1):82\u201388. doi: 10.1002\/jmv.20327","journal-title":"J Med Virol"},{"issue":"2","key":"1_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semcancer.2011.12.007","volume":"22","author":"K Takada","year":"2012","unstructured":"Takada K (2012) Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis. Semin Cancer Biol 22(2):162\u2013165. doi: 10.1016\/j.semcancer.2011.12.007","journal-title":"Semin Cancer Biol"},{"issue":"24","key":"1_CR18","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.1128\/JVI.01521-10","volume":"84","author":"Z Lin","year":"2010","unstructured":"Lin Z, Xu G, Deng N, Taylor C, Zhu D, Flemington EK (2010) Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt\u2019s lymphoma cells. J Virol 84(24):13053\u201313058. doi: 10.1128\/JVI.01521-10","journal-title":"J Virol"},{"issue":"3","key":"1_CR19","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1128\/JVI.06537-11","volume":"86","author":"M Concha","year":"2012","unstructured":"Concha M, Wang X, Cao S, Baddoo M, Fewell C, Lin Z, Hulme W, Hedges D, McBride J, Flemington EK (2012) Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. J Virol 86(3):1458\u20131467. doi: 10.1128\/JVI.06537-11","journal-title":"J Virol"},{"issue":"1","key":"1_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321. doi: 10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"issue":"3","key":"1_CR21","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/JVI.02989-13","volume":"88","author":"T O\u2019Grady","year":"2014","unstructured":"O\u2019Grady T, Cao S, Strong MJ, Concha M, Wang X, Splinter Bondurant S, Adams M, Baddoo M, Srivastav SK, Lin Z, Fewell C, Yin Q, Flemington EK (2014) Global bidirectional transcription of the Epstein-Barr virus genome during reactivation. J Virol 88(3):1604\u20131616. doi: 10.1128\/JVI.02989-13","journal-title":"J Virol"},{"issue":"18","key":"1_CR22","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1128\/JVI.01457-14","volume":"88","author":"MJ Strong","year":"2014","unstructured":"Strong MJ, Baddoo M, Nanbo A, Xu M, Puetter A, Lin Z (2014) Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J Virol 88(18):10696\u201310704. doi: 10.1128\/JVI.01457-14","journal-title":"J Virol"},{"issue":"1","key":"1_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/JVI.02570-14","volume":"89","author":"S Cao","year":"2015","unstructured":"Cao S, Strong MJ, Wang X, Moss WN, Concha M, Lin Z, O\u2019Grady T, Baddoo M, Fewell C, Renne R, Flemington EK (2015) High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project. J Virol 89(1):713\u2013729. doi: 10.1128\/JVI.02570-14","journal-title":"J Virol"},{"issue":"14","key":"1_CR24","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.1128\/JVI.00608-15","volume":"89","author":"S Cao","year":"2015","unstructured":"Cao S, Moss W, O\u2019Grady T, Concha M, Strong MJ, Wang X, Yu Y, Baddoo M, Zhang K, Fewell C, Lin Z, Dong Y, Flemington EK (2015) New noncoding lytic transcripts derived from the Epstein-Barr virus latency origin of replication, oriP, are hyperedited, bind the paraspeckle protein, NONO\/p54nrb, and support viral lytic transcription. J Virol 89(14):7120\u20137132. doi: 10.1128\/JVI.00608-15","journal-title":"J Virol"},{"issue":"7391","key":"1_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P Jr, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603\u2013607. doi: 10.1038\/nature11003","journal-title":"Nature"},{"issue":"7517","key":"1_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202\u2013209. doi: 10.1038\/nature13480","journal-title":"Nature"},{"issue":"19","key":"1_CR27","doi-asserted-by":"publisher","first-page":"10110","DOI":"10.1128\/JVI.01110-15","volume":"89","author":"MJ Strong","year":"2015","unstructured":"Strong MJ, Laskow T, Nakhoul H, Blanchard E, Liu Y, Wang X, Baddoo M, Lin Z, Yin Q, Flemington EK (2015) Latent expression of the Epstein-Barr virus (EBV)-encoded major histocompatibility complex class I TAP inhibitor, BNLF2a, in EBV-positive gastric carcinomas. J Virol 89(19):10110\u201310114. doi: 10.1128\/JVI.01110-15","journal-title":"J Virol"},{"issue":"1","key":"1_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11684-016-0436-0","volume":"10","author":"L Hu","year":"2016","unstructured":"Hu L, Lin Z, Wu Y, Dong J, Zhao B, Cheng Y, Huang P, Xu L, Xia T, Xiong D, Wang H, Li M, Guo L, Kieff E, Zeng Y, Zhong Q, Zeng M (2016) Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing. Front Med 10(1):61\u201375. doi: 10.1007\/s11684-016-0436-0","journal-title":"Front Med"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ymeth.2015.05.001","volume":"90","author":"AA Georges","year":"2015","unstructured":"Georges AA, Frappier L (2015) Proteomics methods for discovering viral-host interactions. Methods 90:21\u201327. doi: 10.1016\/j.ymeth.2015.05.001","journal-title":"Methods"},{"issue":"32","key":"1_CR30","doi-asserted-by":"publisher","first-page":"29987","DOI":"10.1074\/jbc.M303977200","volume":"278","author":"MN Holowaty","year":"2003","unstructured":"Holowaty MN, Zeghouf M, Wu H, Tellam J, Athanasopoulos V, Greenblatt J, Frappier L (2003) Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP\/USP7. J Biol Chem 278(32):29987\u201329994. doi: 10.1074\/jbc.M303977200","journal-title":"J Biol Chem"},{"issue":"1","key":"1_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molcel.2005.02.029","volume":"18","author":"V Saridakis","year":"2005","unstructured":"Saridakis V, Sheng Y, Sarkari F, Holowaty MN, Shire K, Nguyen T, Zhang RG, Liao J, Lee W, Edwards AM, Arrowsmith CH, Frappier L (2005) Structure of the p53 binding domain of HAUSP\/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell 18(1):25\u201336. doi: 10.1016\/j.molcel.2005.02.029","journal-title":"Mol Cell"},{"issue":"10","key":"1_CR32","doi-asserted-by":"publisher","first-page":"e1000170","DOI":"10.1371\/journal.ppat.1000170","volume":"4","author":"N Sivachandran","year":"2008","unstructured":"Sivachandran N, Sarkari F, Frappier L (2008) Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog 4(10):e1000170. doi: 10.1371\/journal.ppat.1000170","journal-title":"PLoS Pathog"},{"issue":"1","key":"1_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/JVI.05623-11","volume":"86","author":"N Sivachandran","year":"2012","unstructured":"Sivachandran N, Dawson CW, Young LS, Liu FF, Middeldorp J, Frappier L (2012) Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol 86(1):60\u201368. doi: 10.1128\/JVI.05623-11","journal-title":"J Virol"},{"issue":"11","key":"1_CR34","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1128\/JVI.00013-12","volume":"86","author":"N Sivachandran","year":"2012","unstructured":"Sivachandran N, Wang X, Frappier L (2012) Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol 86(11):6146\u20136158. doi: 10.1128\/JVI.00013-12","journal-title":"J Virol"},{"issue":"19","key":"1_CR35","doi-asserted-by":"publisher","first-page":"11166","DOI":"10.1128\/JVI.01785-14","volume":"88","author":"S Mansouri","year":"2014","unstructured":"Mansouri S, Pan Q, Blencowe BJ, Claycomb JM, Frappier L (2014) Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer. J Virol 88(19):11166\u201311177. doi: 10.1128\/JVI.01785-14","journal-title":"J Virol"},{"issue":"21","key":"1_CR36","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1128\/JVI.01183-10","volume":"84","author":"N Sivachandran","year":"2010","unstructured":"Sivachandran N, Cao JY, Frappier L (2010) Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol 84(21):11113\u201311123. doi: 10.1128\/JVI.01183-10","journal-title":"J Virol"},{"issue":"3","key":"1_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/3030","volume":"20","author":"ZG Wang","year":"1998","unstructured":"Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, Pandolfi PP (1998) PML is essential for multiple apoptotic pathways. Nat Genet 20(3):266\u2013272. doi: 10.1038\/3073","journal-title":"Nat Genet"},{"issue":"3","key":"1_CR38","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1128\/JVI.79.3.1559-1568.2005","volume":"79","author":"M Murakami","year":"2005","unstructured":"Murakami M, Lan K, Subramanian C, Robertson ES (2005) Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J Virol 79(3):1559\u20131568. doi: 10.1128\/JVI.79.3.1559-1568.2005","journal-title":"J Virol"},{"issue":"1","key":"1_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2010.10.029","volume":"410","author":"J Lu","year":"2011","unstructured":"Lu J, Murakami M, Verma SC, Cai Q, Haldar S, Kaul R, Wasik MA, Middeldorp J, Robertson ES (2011) Epstein-Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410(1):64\u201375. doi: 10.1016\/j.virol.2010.10.029","journal-title":"Virology"},{"issue":"Pt 1","key":"1_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-22822-8_8","volume":"390","author":"DA Thorley-Lawson","year":"2015","unstructured":"Thorley-Lawson DA (2015) EBV persistence\u2014introducing the virus. Curr Top Microbiol Immunol 390(Pt 1):151\u2013209. doi: 10.1007\/978-3-319-22822-8_8","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"1_CR41","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1128\/JVI.02885-13","volume":"88","author":"F Heuts","year":"2014","unstructured":"Heuts F, Rottenberg ME, Salamon D, Rasul E, Adori M, Klein G, Klein E, Nagy N (2014) T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice. J Virol 88(6):3235\u20133245. doi: 10.1128\/JVI.02885-13","journal-title":"J Virol"},{"issue":"5","key":"1_CR42","doi-asserted-by":"publisher","first-page":"e1002697","DOI":"10.1371\/journal.ppat.1002697","volume":"8","author":"E Heath","year":"2012","unstructured":"Heath E, Begue-Pastor N, Chaganti S, Croom-Carter D, Shannon-Lowe C, Kube D, Feederle R, Delecluse HJ, Rickinson AB, Bell AI (2012) Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog 8(5):e1002697. doi: 10.1371\/journal.ppat.1002697","journal-title":"PLoS Pathog"},{"issue":"8","key":"1_CR43","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1073\/pnas.2627966100","volume":"100","author":"J Kurth","year":"2003","unstructured":"Kurth J, Hansmann ML, Rajewsky K, Kuppers R (2003) Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A 100(8):4730\u20134735","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K, Kuppers R (2000) EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13(4):485\u2013495","journal-title":"Immunity"},{"issue":"5","key":"1_CR45","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2353\/ajpath.2008.071186","volume":"173","author":"M Cocco","year":"2008","unstructured":"Cocco M, Bellan C, Tussiwand R, Corti D, Traggiai E, Lazzi S, Mannucci S, Bronz L, Palummo N, Ginanneschi C, Tosi P, Lanzavecchia A, Manz MG, Leoncini L (2008) CD34+ cord blood cell-transplanted Rag2\u2013\/\u2013 gamma(c)\u2013\/\u2013 mice as a model for Epstein-Barr virus infection. Am J Pathol 173(5):1369\u20131378. doi: 10.2353\/ajpath.2008.071186","journal-title":"Am J Pathol"},{"issue":"25","key":"1_CR46","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1182\/blood-2008-08-175828","volume":"113","author":"S Chaganti","year":"2009","unstructured":"Chaganti S, Heath EM, Bergler W, Kuo M, Buettner M, Niedobitek G, Rickinson AB, Bell AI (2009) Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence. Blood 113(25):6372\u20136381. doi: 10.1182\/blood-2008-08-175828","journal-title":"Blood"},{"issue":"25","key":"1_CR47","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2015-08-665000","volume":"126","author":"DM Burns","year":"2015","unstructured":"Burns DM, Tierney R, Shannon-Lowe C, Croudace J, Inman C, Abbotts B, Nagra S, Fox CP, Chaganti S, Craddock CF, Moss P, Rickinson AB, Rowe M, Bell AI (2015) Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event. Blood 126(25):2665\u20132675. doi: 10.1182\/blood-2015-08-665000","journal-title":"Blood"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fgene.2014.00367","volume":"5","author":"HH Niller","year":"2014","unstructured":"Niller HH, Szenthe K, Minarovits J (2014) Epstein-Barr virus-host cell interactions: an epigenetic dialog? Front Genet 5:367. doi: 10.3389\/fgene.2014.00367","journal-title":"Front Genet"},{"issue":"9","key":"1_CR49","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1073\/pnas.0611128104","volume":"104","author":"M Rowe","year":"2007","unstructured":"Rowe M, Glaunsinger B, van Leeuwen D, Zuo J, Sweetman D, Ganem D, Middeldorp J, Wiertz EJ, Ressing ME (2007) Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104(9):3366\u20133371. doi: 10.1073\/pnas.0611128104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1_CR50","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1093\/nar\/gkv212","volume":"43","author":"S Ramasubramanyan","year":"2015","unstructured":"Ramasubramanyan S, Osborn K, Al-Mohammad R, Naranjo Perez-Fernandez IB, Zuo J, Balan N, Godfrey A, Patel H, Peters G, Rowe M, Jenner RG, Sinclair AJ (2015) Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression. Nucleic Acids Res 43(7):3563\u20133577. doi: 10.1093\/nar\/gkv212","journal-title":"Nucleic Acids Res"},{"issue":"46","key":"1_CR51","doi-asserted-by":"publisher","first-page":"16544","DOI":"10.1073\/pnas.1400818111","volume":"111","author":"RM Temple","year":"2014","unstructured":"Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE (2014) Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. Proc Natl Acad Sci U S A 111(46):16544\u201316549. doi: 10.1073\/pnas.1400818111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1_CR52","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","volume":"107","author":"F Suarez","year":"2006","unstructured":"Suarez F, Lortholary O, Hermine O, Lecuit M (2006) Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107(8):3034\u20133044. doi: 10.1182\/blood-2005-09-3679","journal-title":"Blood"},{"issue":"6","key":"1_CR53","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","volume":"156","author":"I Magrath","year":"2012","unstructured":"Magrath I (2012) Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 156(6):744\u2013756. doi: 10.1111\/j.1365-2141.2011.09013.x","journal-title":"Br J Haematol"},{"issue":"1","key":"1_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/ajcp\/aqv011","volume":"145","author":"T Amato","year":"2016","unstructured":"Amato T, Abate F, Piccaluga P, Iacono M, Fallerini C, Renieri A, De Falco G, Ambrosio MR, Mourmouras V, Ogwang M, Calbi V, Rabadan R, Hummel M, Pileri S, Leoncini L, Bellan C (2016) Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic Burkitt lymphoma suggests antigen drive activation of BCR as opposed to sporadic Burkitt lymphoma. Am J Clin Pathol 145(1):116\u2013127. doi: 10.1093\/ajcp\/aqv011","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"1_CR55","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Moller P, MacLeod RA, Pott C, Schreiber S, Trumper L, Loeffler M, Stadler PF, Lichter P, Eils R, Kuppers R, Hummel M, Klapper W, Rosenstiel P, Rosenwald A, Brors B, Siebert R, Project IM-S (2012) Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 44(12):1316\u20131320. doi: 10.1038\/ng.2469","journal-title":"Nat Genet"},{"issue":"7418","key":"1_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116\u2013120. doi: 10.1038\/nature11378","journal-title":"Nature"},{"issue":"12","key":"1_CR57","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS (2012) The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44(12):1321\u20131325. doi: 10.1038\/ng.2468","journal-title":"Nat Genet"},{"issue":"3","key":"1_CR58","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","volume":"106","author":"C Bellan","year":"2005","unstructured":"Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, Amato T, Nyagol J, Sabattini E, Lazure T, Pileri SA, Raphael M, Stein H, Tosi P, Leoncini L (2005) Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106(3):1031\u20131036. doi: 10.1182\/blood-2005-01-0168","journal-title":"Blood"},{"key":"1_CR59","first-page":"173","volume-title":"Advances in viral oncology","author":"GM Lenoir","year":"1987","unstructured":"Lenoir GM, Bornkamm G (1987) Burkitt\u2019s lymphoma, a human cancer model for the study of the multistep development of cancer: proposal for a new scenario. In: Klein G (ed) Advances in viral oncology, vol 7. Raven, New York, pp 173\u2013206"},{"issue":"12","key":"1_CR60","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1182\/blood.V87.12.5279.bloodjournal87125279","volume":"87","author":"I Araujo","year":"1996","unstructured":"Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H (1996) Expression of Epstein-Barr virus-gene products in Burkitt\u2019s lymphoma in northeast Brazil. Blood 87(12):5279\u20135286","journal-title":"Blood"},{"issue":"3","key":"1_CR61","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<326::AID-PATH242>3.0.CO;2-N","volume":"187","author":"I Araujo","year":"1999","unstructured":"Araujo I, Foss HD, Hummel M, Anagnostopoulos I, Barbosa HS, Bittencourt A, Stein H (1999) Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J Pathol 187(3):326\u2013330. doi: 10.1002\/(SICI)1096-9896(199902)187:3<326::AID-PATH242>3.0.CO;2-N","journal-title":"J Pathol"},{"issue":"1","key":"1_CR62","first-page":"HY1","volume":"9","author":"HH Niller","year":"2003","unstructured":"Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J (2003) The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9(1):HY1\u2013HY9","journal-title":"Med Sci Monit"},{"issue":"3","key":"1_CR63","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mehy.2003.11.001","volume":"62","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004) EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 62(3):387\u2013391. doi: 10.1016\/j.mehy.2003.11.001","journal-title":"Med Hypotheses"},{"issue":"11","key":"1_CR64","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.tim.2004.09.006","volume":"12","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004) The LCR of EBV makes Burkitt\u2019s lymphoma endemic. Trends Microbiol 12(11):495\u2013499","journal-title":"Trends Microbiol"},{"issue":"3","key":"1_CR65","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5555\/afhs.2007.7.3.166","volume":"7","author":"J Orem","year":"2007","unstructured":"Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E (2007) Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7(3):166\u2013175. doi: 10.5555\/afhs.2007.7.3.166","journal-title":"Afr Health Sci"},{"issue":"5","key":"1_CR66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/QCO.0b013e328349ac4f","volume":"24","author":"AM Moormann","year":"2011","unstructured":"Moormann AM, Snider CJ, Chelimo K (2011) The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis 24(5):435\u2013441. doi: 10.1097\/QCO.0b013e328349ac4f","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"1_CR67","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood.V85.5.1289.bloodjournal8551289","volume":"85","author":"I Kuhn-Hallek","year":"1995","unstructured":"Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD (1995) Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood 85(5):1289\u20131299","journal-title":"Blood"},{"issue":"10","key":"1_CR68","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","volume":"171","author":"B He","year":"2003","unstructured":"He B, Raab-Traub N, Casali P, Cerutti A (2003) EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol 171(10):5215\u20135224","journal-title":"J Immunol"},{"issue":"5","key":"1_CR69","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.molimm.2006.03.018","volume":"44","author":"M Epeldegui","year":"2007","unstructured":"Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martinez-Maza O (2007) Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 44(5):934\u2013942. doi: 10.1016\/j.molimm.2006.03.018","journal-title":"Mol Immunol"},{"issue":"6","key":"1_CR70","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.semcancer.2009.10.002","volume":"19","author":"A Chene","year":"2009","unstructured":"Chene A, Donati D, Orem J, Mbidde ER, Kironde F, Wahlgren M, Bejarano MT (2009) Endemic Burkitt\u2019s lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Semin Cancer Biol 19(6):411\u2013420. doi: 10.1016\/j.semcancer.2009.10.002","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"1_CR71","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1128\/JVI.01400-09","volume":"84","author":"S Iskra","year":"2010","unstructured":"Iskra S, Kalla M, Delecluse HJ, Hammerschmidt W, Moosmann A (2010) Toll-like receptor agonists synergistically increase proliferation and activation of B cells by Epstein-Barr virus. J Virol 84(7):3612\u20133623. doi: 10.1128\/JVI.01400-09","journal-title":"J Virol"},{"issue":"2\u20133","key":"1_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.actatropica.2011.05.005","volume":"119","author":"O Simone","year":"2011","unstructured":"Simone O, Bejarano MT, Pierce SK, Antonaci S, Wahlgren M, Troye-Blomberg M, Donati D (2011) TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1alpha-driven human polyclonal B-cell activation. Acta Trop 119(2\u20133):144\u2013150. doi: 10.1016\/j.actatropica.2011.05.005","journal-title":"Acta Trop"},{"issue":"5","key":"1_CR73","doi-asserted-by":"publisher","first-page":"e1001338","DOI":"10.1371\/journal.ppat.1001338","volume":"7","author":"C Shannon-Lowe","year":"2011","unstructured":"Shannon-Lowe C, Rowe M (2011) Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. PLoS Pathog 7(5):e1001338. doi: 10.1371\/journal.ppat.1001338","journal-title":"PLoS Pathog"},{"issue":"5","key":"1_CR74","doi-asserted-by":"publisher","first-page":"e1004170","DOI":"10.1371\/journal.ppat.1004170","volume":"10","author":"C Torgbor","year":"2014","unstructured":"Torgbor C, Awuah P, Deitsch K, Kalantari P, Duca KA, Thorley-Lawson DA (2014) A multifactorial role for P. falciparum malaria in endemic Burkitt\u2019s lymphoma pathogenesis. PLoS Pathog 10(5):e1004170. doi: 10.1371\/journal.ppat.1004170","journal-title":"PLoS Pathog"},{"issue":"11","key":"1_CR75","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","volume":"120","author":"GD Victora","year":"2012","unstructured":"Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC (2012) Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 120(11):2240\u20132248. doi: 10.1182\/blood-2012-03-415380","journal-title":"Blood"},{"issue":"2","key":"1_CR76","doi-asserted-by":"publisher","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","volume":"4","author":"R Schmitz","year":"2014","unstructured":"Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM (2014) Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med 4(2):a014282. doi: 10.1101\/cshperspect.a014282","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1_CR77","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cell.2015.07.019","volume":"162","author":"DF Robbiani","year":"2015","unstructured":"Robbiani DF, Deroubaix S, Feldhahn N, Oliveira TY, Callen E, Wang Q, Jankovic M, Silva IT, Rommel PC, Bosque D, Eisenreich T, Nussenzweig A, Nussenzweig MC (2015) Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma. Cell 162(4):727\u2013737. doi: 10.1016\/j.cell.2015.07.019","journal-title":"Cell"},{"issue":"11","key":"1_CR78","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/ni.2428","volume":"13","author":"D Dominguez-Sola","year":"2012","unstructured":"Dominguez-Sola D, Victora GD, Ying CY, Phan RT, Saito M, Nussenzweig MC, Dalla-Favera R (2012) The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13(11):1083\u20131091. doi: 10.1038\/ni.2428","journal-title":"Nat Immunol"},{"issue":"6","key":"1_CR79","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/ijc.29127","volume":"136","author":"JR Wilmore","year":"2015","unstructured":"Wilmore JR, Asito AS, Wei C, Piriou E, Sumba PO, Sanz I, Rochford R (2015) AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus. Int J Cancer 136(6):1371\u20131380. doi: 10.1002\/ijc.29127","journal-title":"Int J Cancer"},{"issue":"2","key":"1_CR80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1084\/jem.20031831","volume":"199","author":"A Faili","year":"2004","unstructured":"Faili A, Aoufouchi S, Weller S, Vuillier F, Stary A, Sarasin A, Reynaud CA, Weill JC (2004) DNA polymerase eta is involved in hypermutation occurring during immunoglobulin class switch recombination. J Exp Med 199(2):265\u2013270. doi: 10.1084\/jem.20031831","journal-title":"J Exp Med"},{"issue":"12","key":"1_CR81","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1128\/JVI.00374-12","volume":"86","author":"KF Bryant","year":"2012","unstructured":"Bryant KF, Yan Z, Dreyfus DH, Knipe DM (2012) Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication. J Virol 86(12):6825\u20136834. doi: 10.1128\/JVI.00374-12","journal-title":"J Virol"},{"issue":"1","key":"1_CR82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-9378-6-10","volume":"6","author":"F Malagon","year":"2011","unstructured":"Malagon F, Gonzalez-Angulo J, Carrasco E, Robert L (2011) Etiopathogenesis of Burkitt\u2019s lymphoma: a lesson from a BL-like in CD1 mouse immune to Plasmodium yoelii yoelii. Infect Agent Cancer 6(1):10. doi: 10.1186\/1750-9378-6-10","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"1_CR83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrmicro1089","volume":"3","author":"R Rochford","year":"2005","unstructured":"Rochford R, Cannon MJ, Moormann AM (2005) Endemic Burkitt\u2019s lymphoma: a polymicrobial disease? Nat Rev Microbiol 3(2):182\u2013187. doi: 10.1038\/nrmicro1089","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"1_CR84","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0035-9203(00)90240-2","volume":"94","author":"C Bosch van den","year":"2000","unstructured":"van den Bosch C, Lloyd G (2000) Chikungunya fever as a risk factor for endemic Burkitt\u2019s lymphoma in Malawi. Trans R Soc Trop Med Hyg 94(6):704\u2013705","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"494758","DOI":"10.1155\/2012\/494758","volume":"2012","author":"C Bosch van den","year":"2012","unstructured":"van den Bosch C (2012) A role for RNA viruses in the pathogenesis of Burkitt\u2019s lymphoma: the need for reappraisal. Adv Hematol 2012:494758. doi: 10.1155\/2012\/494758","journal-title":"Adv Hematol"},{"issue":"12","key":"1_CR86","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1470-2045(04)01650-X","volume":"5","author":"CA Bosch van den","year":"2004","unstructured":"van den Bosch CA (2004) Is endemic Burkitt\u2019s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol 5(12):738\u2013746","journal-title":"Lancet Oncol"},{"issue":"8751","key":"1_CR87","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/0140-6736(91)92861-U","volume":"337","author":"T Aya","year":"1991","unstructured":"Aya T, Kinoshita T, Imai S, Koizumi S, Mizuno F, Osato T, Satoh C, Oikawa T, Kuzumaki N, Ohigashi H et al (1991) Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Lancet 337(8751):1190","journal-title":"Lancet"},{"issue":"2","key":"1_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0304-3835(83)90155-6","volume":"19","author":"F Mizuno","year":"1983","unstructured":"Mizuno F, Koizumi S, Osato T, Kokwaro JO, Ito Y (1983) Chinese and african euphorbiaceae plant extracts: markedly enhancing effect on Epstein-Barr virus-induced transformation. Cancer Lett 19(2):199\u2013205","journal-title":"Cancer Lett"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"149780","DOI":"10.1155\/2012\/149780","volume":"2012","author":"S Mannucci","year":"2012","unstructured":"Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M, Cusi MG, Leoncini L, van den Bosch CA, De Falco G (2012) EBV reactivation and chromosomal polysomies: Euphorbia tirucalli as a possible cofactor in endemic burkitt lymphoma. Adv Hematol 2012:149780. doi: 10.1155\/2012\/149780","journal-title":"Adv Hematol"},{"issue":"9","key":"1_CR90","doi-asserted-by":"publisher","first-page":"e46005","DOI":"10.1371\/journal.pone.0046005","volume":"7","author":"C Minnicelli","year":"2012","unstructured":"Minnicelli C, Barros MH, Klumb CE, Romano SO, Zalcberg IR, Hassan R (2012) Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma. PLoS One 7(9):e46005. doi: 10.1371\/journal.pone.0046005","journal-title":"PLoS One"},{"issue":"3","key":"1_CR91","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4269\/ajtmh.13-0616","volume":"91","author":"CI Oduor","year":"2014","unstructured":"Oduor CI, Chelimo K, Ouma C, Mulama DH, Foley J, Vulule J, Bailey JA, Moormann AM (2014) Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma. Am J Trop Med Hyg 91(3):649\u2013654. doi: 10.4269\/ajtmh.13-0616","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"1_CR92","first-page":"39","volume":"24","author":"MC Pike","year":"1970","unstructured":"Pike MC, Morrow RH, Kisuule A, Mafigiri J (1970) Burkitt\u2019s lymphoma and sickle cell trait. Br J Prev Soc Med 24(1):39\u201341","journal-title":"Br J Prev Soc Med"},{"issue":"3","key":"1_CR93","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ijc.28378","volume":"134","author":"DH Mulama","year":"2014","unstructured":"Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG, Otieno J, Vulule J, Moormann AM (2014) Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case\u2013control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer 134(3):645\u2013653. doi: 10.1002\/ijc.28378","journal-title":"Int J Cancer"},{"key":"1_CR94","first-page":"207","volume-title":"Advances in viral oncology","author":"G Klein","year":"1987","unstructured":"Klein G (1987) In defense of the \u201cold\u201d Burkitt lymphoma scenario. In: Klein G (ed) Advances in viral oncology, vol 7. Raven, New York, pp 207\u2013211"},{"issue":"6","key":"1_CR95","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.semcancer.2009.07.007","volume":"19","author":"MJ Allday","year":"2009","unstructured":"Allday MJ (2009) How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt\u2019s lymphoma? Semin Cancer Biol 19(6):366\u2013376. doi: 10.1016\/j.semcancer.2009.07.007","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1_CR96","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1556\/AMicr.51.2004.4.7","volume":"51","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Rahmann S, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004) A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a \u201cping-pong evolution\u201d model for persisting viruses and their hosts. A review. Acta Microbiol Immunol Hung 51(4):469\u2013484. doi: 10.1556\/AMicr.51.2004.4.7","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"6","key":"1_CR97","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.exphem.2006.02.021","volume":"34","author":"G Khan","year":"2006","unstructured":"Khan G (2006) Epstein-Barr virus and the germinal center B cells. Exp Hematol 34(6):695\u2013696. doi: 10.1016\/j.exphem.2006.02.021","journal-title":"Exp Hematol"},{"issue":"23","key":"1_CR98","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1128\/JVI.78.23.13253-13261.2004","volume":"78","author":"D Panagopoulos","year":"2004","unstructured":"Panagopoulos D, Victoratos P, Alexiou M, Kollias G, Mosialos G (2004) Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo. J Virol 78(23):13253\u201313261. doi: 10.1128\/JVI.78.23.13253-13261.2004","journal-title":"J Virol"},{"issue":"12","key":"1_CR99","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1182\/blood-2006-05-021303","volume":"108","author":"S Tobollik","year":"2006","unstructured":"Tobollik S, Meyer L, Buettner M, Klemmer S, Kempkes B, Kremmer E, Niedobitek G, Jungnickel B (2006) Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth. Blood 108(12):3859\u20133864. doi: 10.1182\/blood-2006-05-021303","journal-title":"Blood"},{"issue":"5","key":"1_CR100","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1128\/JVI.01822-06","volume":"81","author":"F Boccellato","year":"2007","unstructured":"Boccellato F, Anastasiadou E, Rosato P, Kempkes B, Frati L, Faggioni A, Trivedi P (2007) EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin\u2019s lymphoma cells. J Virol 81(5):2274\u20132282. doi: 10.1128\/JVI.01822-06","journal-title":"J Virol"},{"issue":"8","key":"1_CR101","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1128\/JVI.02609-08","volume":"83","author":"JE Roughan","year":"2009","unstructured":"Roughan JE, Thorley-Lawson DA (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol 83(8):3968\u20133976. doi: 10.1128\/JVI.02609-08","journal-title":"J Virol"},{"issue":"2","key":"1_CR102","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/JVI.01780-09","volume":"84","author":"JE Roughan","year":"2010","unstructured":"Roughan JE, Torgbor C, Thorley-Lawson DA (2010) Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol 84(2):1158\u20131168. doi: 10.1128\/JVI.01780-09","journal-title":"J Virol"},{"issue":"10","key":"1_CR103","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nm758","volume":"8","author":"G Kelly","year":"2002","unstructured":"Kelly G, Bell A, Rickinson A (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8(10):1098\u20131104. doi: 10.1038\/nm758","journal-title":"Nat Med"},{"issue":"9","key":"1_CR104","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","volume":"85","author":"J Limpens","year":"1995","unstructured":"Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85(9):2528\u20132536","journal-title":"Blood"},{"issue":"14","key":"1_CR105","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1073\/pnas.92.14.6577","volume":"92","author":"JR Muller","year":"1995","unstructured":"Muller JR, Janz S, Goedert JJ, Potter M, Rabkin CS (1995) Persistence of immunoglobulin heavy chain\/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci U S A 92(14):6577\u20136581","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1_CR106","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/(SICI)1521-1878(200005)22:5<414::AID-BIES3>3.0.CO;2-5","volume":"22","author":"G Klein","year":"2000","unstructured":"Klein G (2000) Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes. Bioessays 22(5):414\u2013422. doi: 10.1002\/(SICI)1521-1878(200005)22:5<414::AID-BIES3>3.0.CO;2-5","journal-title":"Bioessays"},{"issue":"13","key":"1_CR107","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350(13):1328\u20131337. doi: 10.1056\/NEJMra032015","journal-title":"N Engl J Med"},{"issue":"25","key":"1_CR108","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1056\/NEJM200406173502518","volume":"350","author":"G Rossi","year":"2004","unstructured":"Rossi G, Bonetti F (2004) EBV and Burkitt\u2019s lymphoma. N Engl J Med 350(25):2621","journal-title":"N Engl J Med"},{"issue":"25","key":"1_CR109","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1056\/NEJM200406173502518","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA (2004) EBV and Burkitt\u2019s lymphoma. N Engl J Med 350(25):2621","journal-title":"N Engl J Med"},{"issue":"40","key":"1_CR110","doi-asserted-by":"publisher","first-page":"14935","DOI":"10.1073\/pnas.0509988103","volume":"103","author":"GL Kelly","year":"2006","unstructured":"Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB (2006) Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc Natl Acad Sci U S A 103(40):14935\u201314940. doi: 10.1073\/pnas.0509988103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1_CR111","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2009.07.004","volume":"19","author":"M Rowe","year":"2009","unstructured":"Rowe M, Kelly GL, Bell AI, Rickinson AB (2009) Burkitt\u2019s lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol 19(6):377\u2013388. doi: 10.1016\/j.semcancer.2009.07.004","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"1_CR112","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1073\/pnas.0812575106","volume":"106","author":"TF Schulz","year":"2009","unstructured":"Schulz TF, Cordes S (2009) Is the Epstein-Barr virus EBNA-1 protein an oncogen? Proc Natl Acad Sci U S A 106(7):2091\u20132092. doi: 10.1073\/pnas.0812575106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1_CR113","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2141.2011.09007.x","volume":"156","author":"S Gromminger","year":"2012","unstructured":"Gromminger S, Mautner J, Bornkamm GW (2012) Burkitt lymphoma: the role of Epstein-Barr virus revisited. Br J Haematol 156(6):719\u2013729","journal-title":"Br J Haematol"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer.2014.04.004","volume":"26","author":"AB Rickinson","year":"2014","unstructured":"Rickinson AB (2014) Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 26:99\u2013115. doi: 10.1016\/j.semcancer.2014.04.004","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1_CR115","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semcancer.2009.07.002","volume":"19","author":"GW Bornkamm","year":"2009","unstructured":"Bornkamm GW (2009) Epstein-Barr virus and its role in the pathogenesis of Burkitt\u2019s lymphoma: an unresolved issue. Semin Cancer Biol 19(6):351\u2013365. doi: 10.1016\/j.semcancer.2009.07.002","journal-title":"Semin Cancer Biol"},{"key":"1_CR116","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4614-3345-3_8","volume-title":"Patho-epigenetics of disease","author":"HH Niller","year":"2012","unstructured":"Niller HH, Banati F, Ay E, Minarovits J (2012) Epigenetic changes in virus-associated neoplasms. In: Minarovits J, Niller HH (eds) Patho-epigenetics of disease. Springer, New York, pp 179\u2013225"},{"issue":"7","key":"1_CR117","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrmicro3290","volume":"12","author":"C Nunes-Alves","year":"2014","unstructured":"Nunes-Alves C (2014) Parasite biology: Piecing it together. Nat Rev Microbiol 12(7):462\u2013463","journal-title":"Nat Rev Microbiol"},{"issue":"3\u20134","key":"1_CR118","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1155\/2001\/75259","volume":"8","author":"PF Piguet","year":"2001","unstructured":"Piguet PF, Da Laperrousaz C, Vesin C, Donati Y (2001) Incidence of apoptosis in the lymphoid organs of normal or malaria infected mice is decreased in CD18 and urokinase-receptor (UPAR, CD87) deficient mice. Dev Immunol 8(3\u20134):183\u2013191","journal-title":"Dev Immunol"},{"issue":"3","key":"1_CR119","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood.V66.3.655.655","volume":"66","author":"SP Kalter","year":"1985","unstructured":"Kalter SP, Riggs SA, Cabanillas F, Butler JJ, Hagemeister FB, Mansell PW, Newell GR, Velasquez WS, Salvador P, Barlogie B et al (1985) Aggressive non-Hodgkin\u2019s lymphomas in immunocompromised homosexual males. Blood 66(3):655\u2013659","journal-title":"Blood"},{"issue":"9","key":"1_CR120","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/656479","volume":"202","author":"Y Richard","year":"2010","unstructured":"Richard Y, Amiel C, Jeantils V, Mestivier D, Portier A, Dhello G, Feuillard J, Creidy R, Nicolas JC, Raphael M (2010) Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus-infected patients before and after antiretroviral therapy. J Infect Dis 202(9):1424\u20131434. doi: 10.1086\/656479","journal-title":"J Infect Dis"},{"issue":"2","key":"1_CR121","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/jbiol34","volume":"5","author":"OR Millington","year":"2006","unstructured":"Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer JM (2006) Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol 5(2):5. doi: 10.1186\/jbiol34","journal-title":"J Biol"},{"issue":"31","key":"1_CR122","doi-asserted-by":"publisher","first-page":"E2117","DOI":"10.1073\/pnas.1206573109","volume":"109","author":"T Sun","year":"2012","unstructured":"Sun T, Holowka T, Song Y, Zierow S, Leng L, Chen Y, Xiong H, Griffith J, Nouraie M, Thuma PE, Lolis E, Janse CJ, Gordeuk VR, Augustijn K, Bucala R (2012) A plasmodium-encoded cytokine suppresses T-cell immunity during malaria. Proc Natl Acad Sci U S A 109(31):E2117\u2013E2126. doi: 10.1073\/pnas.1206573109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1_CR123","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4049\/jimmunol.1401745","volume":"194","author":"CE White","year":"2015","unstructured":"White CE, Villarino NF, Sloan SS, Ganusov VV, Schmidt NW (2015) Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol 194(2):697\u2013708. doi: 10.4049\/jimmunol.1401745","journal-title":"J Immunol"},{"issue":"1","key":"1_CR124","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/TP.0b013e318277e344","volume":"95","author":"T Schober","year":"2013","unstructured":"Schober T, Framke T, Kreipe H, Schulz TF, Grosshennig A, Hussein K, Baumann U, Pape L, Schubert S, Wingen AM, Jack T, Koch A, Klein C, Maecker-Kolhoff B (2013) Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Transplantation 95(1):240\u2013246. doi: 10.1097\/TP.0b013e318277e344","journal-title":"Transplantation"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1038\/emm.2014.102","volume":"47","author":"E Tse","year":"2015","unstructured":"Tse E, Kwong YL (2015) Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target. Exp Mol Med 47:e136. doi: 10.1038\/emm.2014.102","journal-title":"Exp Mol Med"},{"issue":"4","key":"1_CR126","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.190.4.567","volume":"190","author":"GJ Babcock","year":"1999","unstructured":"Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA (1999) Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190(4):567\u2013576","journal-title":"J Exp Med"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"150835","DOI":"10.1155\/2013\/150835","volume":"2013","author":"J Morscio","year":"2013","unstructured":"Morscio J, Dierickx D, Tousseyn T (2013) Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? Clin Dev Immunol 2013:150835. doi: 10.1155\/2013\/150835","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"1_CR128","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","volume":"369","author":"MR Petrara","year":"2015","unstructured":"Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A (2015) Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Cancer Lett 369(1):37\u201344. doi: 10.1016\/j.canlet.2015.08.007","journal-title":"Cancer Lett"},{"issue":"1","key":"1_CR129","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ (2013) CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev 254(1):54\u201364. doi: 10.1111\/imr.12066","journal-title":"Immunol Rev"},{"issue":"2","key":"1_CR130","doi-asserted-by":"publisher","first-page":"e2009032","DOI":"10.4084\/MJHID.2009.032","volume":"1","author":"M Bibas","year":"2009","unstructured":"Bibas M, Antinori A (2009) EBV and HIV-related lymphoma. Mediterr J Hematol Infect Dis 1(2):e2009032. doi: 10.4084\/MJHID.2009.032","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"1_CR131","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","volume":"113","author":"A Carbone","year":"2009","unstructured":"Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF (2009) HIV-associated lymphomas and gamma-herpesviruses. Blood 113(6):1213\u20131224. doi: 10.1182\/blood-2008-09-180315","journal-title":"Blood"},{"issue":"6","key":"1_CR132","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1371\/journal.ppat.0030080","volume":"3","author":"A Chene","year":"2007","unstructured":"Chene A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT (2007) A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 3(6):e80. doi: 10.1371\/journal.ppat.0030080","journal-title":"PLoS Pathog"},{"issue":"3 Pt 2","key":"1_CR133","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43(3 Pt 2):831\u2013840","journal-title":"Cell"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-319-22834-1_4","volume":"391","author":"A Kieser","year":"2015","unstructured":"Kieser A, Sterz KR (2015) The latent membrane protein 1 (LMP1). Curr Top Microbiol Immunol 391:119\u2013149. doi: 10.1007\/978-3-319-22834-1_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.coviro.2015.09.007","volume":"14","author":"B Kempkes","year":"2015","unstructured":"Kempkes B, Robertson ES (2015) Epstein-Barr virus latency: current and future perspectives. Curr Opin Virol 14:138\u2013144. doi: 10.1016\/j.coviro.2015.09.007","journal-title":"Curr Opin Virol"},{"issue":"13","key":"1_CR136","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1182\/blood-2014-08-594176","volume":"125","author":"V Lajoie","year":"2015","unstructured":"Lajoie V, Lemieux B, Sawan B, Lichtensztejn D, Lichtensztejn Z, Wellinger R, Mai S, Knecht H (2015) LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates. Blood 125(13):2101\u20132110. doi: 10.1182\/blood-2014-08-594176","journal-title":"Blood"},{"issue":"18","key":"1_CR137","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1101\/gad.1346005","volume":"19","author":"T Lange de","year":"2005","unstructured":"de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19(18):2100\u20132110. doi: 10.1101\/gad.1346005","journal-title":"Genes Dev"},{"issue":"2","key":"1_CR138","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3390\/cancers5020714","volume":"5","author":"H Knecht","year":"2013","unstructured":"Knecht H, Righolt C, Mai S (2013) Genomic instability: the driving force behind refractory\/relapsing Hodgkin\u2019s lymphoma. Cancers (Basel) 5(2):714\u2013725. doi: 10.3390\/cancers5020714","journal-title":"Cancers (Basel)"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2121-11-99","volume":"11","author":"H Knecht","year":"2010","unstructured":"Knecht H, Bruderlein S, Wegener S, Lichtensztejn D, Lichtensztejn Z, Lemieux B, Moller P, Mai S (2010) 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including \u201ct-stumps\u201d. BMC Cell Biol 11:99. doi: 10.1186\/1471-2121-11-99","journal-title":"BMC Cell Biol"},{"issue":"8","key":"1_CR140","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/jcb.24800","volume":"115","author":"CH Righolt","year":"2014","unstructured":"Righolt CH, Guffei A, Knecht H, Young IT, Stallinga S, van Vliet LJ, Mai S (2014) Differences in nuclear DNA organization between lymphocytes, Hodgkin and Reed-Sternberg cells revealed by structured illumination microscopy. J Cell Biochem 115(8):1441\u20131448. doi: 10.1002\/jcb.24800","journal-title":"J Cell Biochem"},{"issue":"7","key":"1_CR141","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/jcb.25456","volume":"117","author":"CH Righolt","year":"2016","unstructured":"Righolt CH, Knecht H, Mai S (2016) DNA superresolution structure of Reed-Sternberg cells differs between long-lasting remission versus relapsing Hodgkin\u2019s lymphoma patients. J Cell Biochem 117(7):1633\u20131637. doi: 10.1002\/jcb.25456","journal-title":"J Cell Biochem"},{"issue":"2","key":"1_CR142","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1101\/gr.157743.113","volume":"24","author":"KD Hansen","year":"2014","unstructured":"Hansen KD, Sabunciyan S, Langmead B, Nagy N, Curley R, Klein G, Klein E, Salamon D, Feinberg AP (2014) Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization. Genome Res 24(2):177\u2013184. doi: 10.1101\/gr.157743.113","journal-title":"Genome Res"},{"issue":"8","key":"1_CR143","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/leu.2013.4","volume":"27","author":"B Kreck","year":"2013","unstructured":"Kreck B, Richter J, Ammerpohl O, Barann M, Esser D, Petersen BS, Vater I, Murga Penas EM, Bormann Chung CA, Seisenberger S, Lee Boyd V, Smallwood S, Drexler HG, Macleod RA, Hummel M, Krueger F, Hasler R, Schreiber S, Rosenstiel P, Franke A, Siebert R (2013) Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. Leukemia 27(8):1751\u20131753. doi: 10.1038\/leu.2013.4","journal-title":"Leukemia"},{"issue":"11","key":"1_CR144","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.3413","volume":"47","author":"H Kretzmer","year":"2015","unstructured":"Kretzmer H, Bernhart SH, Wang W, Haake A, Weniger MA, Bergmann AK, Betts MJ, Carrillo-de-Santa-Pau E, Doose G, Gutwein J, Richter J, Hovestadt V, Huang B, Rico D, Juhling F, Kolarova J, Lu Q, Otto C, Wagener R, Arnolds J, Burkhardt B, Claviez A, Drexler HG, Eberth S, Eils R, Flicek P, Haas S, Hummel M, Karsch D, Kerstens HH, Klapper W, Kreuz M, Lawerenz C, Lenze D, Loeffler M, Lopez C, MacLeod RA, Martens JH, Kulis M, Martin-Subero JI, Moller P, Nagel I, Picelli S, Vater I, Rohde M, Rosenstiel P, Rosolowski M, Russell RB, Schilhabel M, Schlesner M, Stadler PF, Szczepanowski M, Trumper L, Stunnenberg HG, ICGC MMML-Seq Project, BLUEPRINT Project, Kuppers R, Ammerpohl O, Lichter P, Siebert R, Hoffmann S, Radlwimmer B (2015) DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control. Nat Genet 47(11):1316\u20131325. doi: 10.1038\/ng.3413","journal-title":"Nat Genet"},{"issue":"7","key":"1_CR145","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ng.3291","volume":"47","author":"M Kulis","year":"2015","unstructured":"Kulis M, Merkel A, Heath S, Queiros AC, Schuyler RP, Castellano G, Beekman R, Raineri E, Esteve A, Clot G, Verdaguer-Dot N, Duran-Ferrer M, Russinol N, Vilarrasa-Blasi R, Ecker S, Pancaldi V, Rico D, Agueda L, Blanc J, Richardson D, Clarke L, Datta A, Pascual M, Agirre X, Prosper F, Alignani D, Paiva B, Caron G, Fest T, Muench MO, Fomin ME, Lee ST, Wiemels JL, Valencia A, Gut M, Flicek P, Stunnenberg HG, Siebert R, Kuppers R, Gut IG, Campo E, Martin-Subero JI (2015) Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet 47(7):746\u2013756. doi: 10.1038\/ng.3291","journal-title":"Nat Genet"},{"issue":"9","key":"1_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006986","volume":"4","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, Alvarez S, Bruggemann M, Bug S, Calasanz MJ, Deckert M, Dreyling M, Du MQ, Durig J, Dyer MJ, Fan JB, Gesk S, Hansmann ML, Harder L, Hartmann S, Klapper W, Kuppers R, Montesinos-Rongen M, Nagel I, Pott C, Richter J, Roman-Gomez J, Seifert M, Stein H, Suela J, Trumper L, Vater I, Prosper F, Haferlach C, Cruz Cigudosa J, Siebert R (2009) A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 4(9), e6986. doi: 10.1371\/journal.pone.0006986","journal-title":"PLoS One"},{"issue":"11","key":"1_CR147","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1182\/blood-2008-04-152900","volume":"113","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, Wickham-Garcia E, Rosolowski M, Richter J, Lopez-Serra L, Ballestar E, Berger H, Agirre X, Bernd HW, Calvanese V, Cogliatti SB, Drexler HG, Fan JB, Fraga MF, Hansmann ML, Hummel M, Klapper W, Korn B, Kuppers R, Macleod RA, Moller P, Ott G, Pott C, Prosper F, Rosenwald A, Schwaenen C, Schubeler D, Seifert M, Sturzenhofecker B, Weber M, Wessendorf S, Loeffler M, Trumper L, Stein H, Spang R, Esteller M, Barker D, Hasenclever D, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe (2009) New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113(11):2488\u20132497. doi: 10.1182\/blood-2008-04-152900","journal-title":"Blood"},{"issue":"2","key":"1_CR148","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/epi.14.79","volume":"7","author":"L Li","year":"2015","unstructured":"Li L, Zhang Y, Fan Y, Sun K, Su X, Du Z, Tsao SW, Loh TK, Sun H, Chan AT, Zeng YX, Chan WY, Chan FK, Tao Q (2015) Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes. Epigenomics 7(2):155\u2013173. doi: 10.2217\/epi.14.79","journal-title":"Epigenomics"},{"issue":"14","key":"1_CR149","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-11-3919","volume":"72","author":"A Kaneda","year":"2012","unstructured":"Kaneda A, Matsusaka K, Aburatani H, Fukayama M (2012) Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res 72(14):3445\u20133450. doi: 10.1158\/0008-5472.CAN-11-3919","journal-title":"Cancer Res"},{"issue":"2","key":"1_CR150","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcancer.2011.12.011","volume":"22","author":"KW Lo","year":"2012","unstructured":"Lo KW, Chung GT, To KF (2012) Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 22(2):79\u201386. doi: 10.1016\/j.semcancer.2011.12.011","journal-title":"Semin Cancer Biol"},{"key":"1_CR151","doi-asserted-by":"crossref","unstructured":"Niller HH, Banati F, Minarovits J (2014) Epigenetic alterations in nasopharyngeal carcinoma and Epstein-Barr virus (EBV) associated gastric carcinoma: a lesson in contrasts. J Nasopharyng Carcinoma 1:e9. doi:10.15383\/jnpc.9","DOI":"10.15383\/jnpc.9"},{"issue":"10","key":"1_CR152","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5483\/BMBRep.2014.47.10.164","volume":"47","author":"YJ Yoon","year":"2014","unstructured":"Yoon YJ, Kim OY, Gho YS (2014) Extracellular vesicles as emerging intercellular communicasomes. BMB Rep 47(10):531\u2013539","journal-title":"BMB Rep"},{"issue":"10","key":"1_CR153","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1128\/JVI.02470-14","volume":"89","author":"DG Meckes Jr","year":"2015","unstructured":"Meckes DG Jr (2015) Exosomal communication goes viral. J Virol 89(10):5200\u20135203. doi: 10.1128\/JVI.02470-14","journal-title":"J Virol"},{"issue":"1","key":"1_CR154","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbalip.2013.10.004","volume":"1841","author":"M Record","year":"2014","unstructured":"Record M, Carayon K, Poirot M, Silvente-Poirot S (2014) Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 1841(1):108\u2013120. doi: 10.1016\/j.bbalip.2013.10.004","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1_CR155","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/annonc\/mdv604","volume":"27","author":"FA San Lucas","year":"2016","unstructured":"San Lucas FA, Allenson K, Bernard V, Castillo J, Kim DU, Ellis K, Ehli EA, Davies GE, Petersen JL, Li D, Wolff R, Katz M, Varadhachary G, Wistuba I, Maitra A, Alvarez H (2016) Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Ann Oncol 27(4):635\u2013641. doi: 10.1093\/annonc\/mdv604","journal-title":"Ann Oncol"},{"issue":"5","key":"1_CR156","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4161\/cib.3.5.12339","volume":"3","author":"A Zomer","year":"2010","unstructured":"Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, Pegtel DM (2010) Exosomes: fit to deliver small RNA. Commun Integr Biol 3(5):447\u2013450. doi: 10.4161\/cib.3.5.12339","journal-title":"Commun Integr Biol"},{"issue":"2","key":"1_CR157","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1083\/jcb.201506084","volume":"213","author":"W Heusermann","year":"2016","unstructured":"Heusermann W, Hean J, Trojer D, Steib E, von Bueren S, Graff-Meyer A, Genoud C, Martin K, Pizzato N, Voshol J, Morrissey DV, Andaloussi SE, Wood MJ, Meisner-Kober NC (2016) Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J Cell Biol 213(2):173\u2013184. doi: 10.1083\/jcb.201506084","journal-title":"J Cell Biol"},{"issue":"9","key":"1_CR158","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molmed.2012.07.002","volume":"18","author":"Y Liu","year":"2012","unstructured":"Liu Y, Li X (2012) Darwin\u2019s pangenesis and molecular medicine. Trends Mol Med 18(9):506\u2013508. doi: 10.1016\/j.molmed.2012.07.002","journal-title":"Trends Mol Med"},{"issue":"18","key":"1_CR159","doi-asserted-by":"publisher","first-page":"10334","DOI":"10.1128\/JVI.01310-13","volume":"87","author":"A Nanbo","year":"2013","unstructured":"Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H (2013) Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. J Virol 87(18):10334\u201310347. doi: 10.1128\/JVI.01310-13","journal-title":"J Virol"},{"issue":"2","key":"1_CR160","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4049\/jimmunol.165.2.663","volume":"165","author":"DF Dukers","year":"2000","unstructured":"Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, Meijer CJ, Bloemena E, Middeldorp JM (2000) Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165(2):663\u2013670","journal-title":"J Immunol"},{"issue":"Pt 7","key":"1_CR161","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1099\/vir.0.18944-0","volume":"84","author":"J Flanagan","year":"2003","unstructured":"Flanagan J, Middeldorp J, Sculley T (2003) Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol 84(Pt 7):1871\u20131879. doi: 10.1099\/vir.0.18944-0","journal-title":"J Gen Virol"},{"issue":"7","key":"1_CR162","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/ijc.22844","volume":"121","author":"S Ceccarelli","year":"2007","unstructured":"Ceccarelli S, Visco V, Raffa S, Wakisaka N, Pagano JS, Torrisi MR (2007) Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int J Cancer 121(7):1494\u20131506. doi: 10.1002\/ijc.22844","journal-title":"Int J Cancer"},{"issue":"37","key":"1_CR163","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1038\/onc.2014.66","volume":"33","author":"M Aga","year":"2014","unstructured":"Aga M, Bentz GL, Raffa S, Torrisi MR, Kondo S, Wakisaka N, Yoshizaki T, Pagano JS, Shackelford J (2014) Exosomal HIF1alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene 33(37):4613\u20134622. doi: 10.1038\/onc.2014.66","journal-title":"Oncogene"},{"issue":"5","key":"1_CR164","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/1566524014666140603115831","volume":"14","author":"H Mujcic","year":"2014","unstructured":"Mujcic H, Hill RP, Koritzinsky M, Wouters BG (2014) Hypoxia signaling and the metastatic phenotype. Curr Mol Med 14(5):565\u2013579","journal-title":"Curr Mol Med"},{"issue":"9","key":"1_CR165","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1242\/dmm.016287","volume":"7","author":"BM Zwaans","year":"2014","unstructured":"Zwaans BM, Lombard DB (2014) Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming. Dis Model Mech 7(9):1023\u20131032. doi: 10.1242\/dmm.016287","journal-title":"Dis Model Mech"},{"issue":"47","key":"1_CR166","doi-asserted-by":"publisher","first-page":"20370","DOI":"10.1073\/pnas.1014194107","volume":"107","author":"DG Meckes Jr","year":"2010","unstructured":"Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N (2010) Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 107(47):20370\u201320375. doi: 10.1073\/pnas.1014194107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1_CR167","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.virol.2006.10.046","volume":"360","author":"M Ikeda","year":"2007","unstructured":"Ikeda M, Longnecker R (2007) Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 360(2):461\u2013468. doi: 10.1016\/j.virol.2006.10.046","journal-title":"Virology"},{"issue":"7","key":"1_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069827","volume":"8","author":"ME Ariza","year":"2013","unstructured":"Ariza ME, Rivailler P, Glaser R, Chen M, Williams MV (2013) Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. PLoS One 8(7), e69827. doi: 10.1371\/journal.pone.0069827","journal-title":"PLoS One"},{"issue":"31","key":"1_CR169","doi-asserted-by":"publisher","first-page":"E2925","DOI":"10.1073\/pnas.1303906110","volume":"110","author":"DG Meckes Jr","year":"2013","unstructured":"Meckes DG Jr, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N (2013) Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci U S A 110(31):E2925\u2013E2933. doi: 10.1073\/pnas.1303906110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1_CR170","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.4049\/jimmunol.1302068","volume":"192","author":"C Gutzeit","year":"2014","unstructured":"Gutzeit C, Nagy N, Gentile M, Lyberg K, Gumz J, Vallhov H, Puga I, Klein E, Gabrielsson S, Cerutti A, Scheynius A (2014) Exosomes derived from Burkitt\u2019s lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells. J Immunol 192(12):5852\u20135862. doi: 10.4049\/jimmunol.1302068","journal-title":"J Immunol"},{"issue":"2","key":"1_CR171","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2013.05.012","volume":"337","author":"A Canitano","year":"2013","unstructured":"Canitano A, Venturi G, Borghi M, Ammendolia MG, Fais S (2013) Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs. Cancer Lett 337(2):193\u2013199. doi: 10.1016\/j.canlet.2013.05.012","journal-title":"Cancer Lett"},{"issue":"6","key":"1_CR172","doi-asserted-by":"publisher","first-page":"e99163","DOI":"10.1371\/journal.pone.0099163","volume":"9","author":"W Ahmed","year":"2014","unstructured":"Ahmed W, Philip PS, Tariq S, Khan G (2014) Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. PLoS One 9(6):e99163. doi: 10.1371\/journal.pone.0099163","journal-title":"PLoS One"},{"issue":"1","key":"1_CR173","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.1763","volume":"24","author":"W Ahmed","year":"2014","unstructured":"Ahmed W, Khan G (2014) The labyrinth of interactions of Epstein-Barr virus-encoded small RNAs. Rev Med Virol 24(1):3\u201314. doi: 10.1002\/rmv.1763","journal-title":"Rev Med Virol"},{"key":"1_CR174","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-319-22834-1_6","volume":"391","author":"RL Skalsky","year":"2015","unstructured":"Skalsky RL, Cullen BR (2015) EBV noncoding RNAs. Curr Top Microbiol Immunol 391:181\u2013217. doi: 10.1007\/978-3-319-22834-1_6","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR175","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.virusres.2015.08.007","volume":"212","author":"D Iwakiri","year":"2016","unstructured":"Iwakiri D (2016) Multifunctional non-coding Epstein-Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis. Virus Res 212:30\u201338. doi: 10.1016\/j.virusres.2015.08.007","journal-title":"Virus Res"},{"issue":"10","key":"1_CR176","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1084\/jem.20081761","volume":"206","author":"D Iwakiri","year":"2009","unstructured":"Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T, Imai S, Fujieda M, Kawa K, Takada K (2009) Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206(10):2091\u20132099. doi: 10.1084\/jem.20081761","journal-title":"J Exp Med"},{"issue":"4","key":"1_CR177","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/08916930802024772","volume":"41","author":"HH Niller","year":"2008","unstructured":"Niller HH, Wolf H, Minarovits J (2008) Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41(4):298\u2013328. doi: 10.1080\/08916930802024772","journal-title":"Autoimmunity"},{"key":"1_CR178","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/emm.2014.88","volume":"47","author":"S Fujiwara","year":"2015","unstructured":"Fujiwara S, Imadome K, Takei M (2015) Modeling EBV infection and pathogenesis in new-generation humanized mice. Exp Mol Med 47:e135. doi: 10.1038\/emm.2014.88","journal-title":"Exp Mol Med"},{"issue":"5","key":"1_CR179","doi-asserted-by":"publisher","first-page":"E587","DOI":"10.1073\/pnas.1518130113","volume":"113","author":"SR Baglio","year":"2016","unstructured":"Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Leveille N, Rinkel RN, Hopmans ES, Swaminathan S, Verkuijlen SA, Scheffer GL, van Kuppeveld FJ, de Gruijl TD, Bultink IE, Jordanova ES, Hackenberg M, Piersma SR, Knol JC, Voskuyl AE, Wurdinger T, Jimenez CR, Middeldorp JM, Pegtel DM (2016) Sensing of latent EBV infection through exosomal transfer of 5\u2032pppRNA. Proc Natl Acad Sci U S A 113(5):E587\u2013E596. doi: 10.1073\/pnas.1518130113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"1_CR180","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1073\/pnas.0914843107","volume":"107","author":"DM Pegtel","year":"2010","unstructured":"Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T, Middeldorp JM (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107(14):6328\u20136333. doi: 10.1073\/pnas.0914843107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1_CR181","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nri2252","volume":"8","author":"HF Lodish","year":"2008","unstructured":"Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8(2):120\u2013130. doi: 10.1038\/nri2252","journal-title":"Nat Rev Immunol"},{"key":"1_CR182","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1743-422X-7-271","volume":"7","author":"C Gourzones","year":"2010","unstructured":"Gourzones C, Gelin A, Bombik I, Klibi J, Verillaud B, Guigay J, Lang P, Temam S, Schneider V, Amiel C, Baconnais S, Jimenez AS, Busson P (2010) Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J 7:271. doi: 10.1186\/1743-422X-7-271","journal-title":"Virol J"},{"issue":"13","key":"1_CR183","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.febslet.2015.04.036","volume":"589","author":"T Janas","year":"2015","unstructured":"Janas T, Janas MM, Sapon K, Janas T (2015) Mechanisms of RNA loading into exosomes. FEBS Lett 589(13):1391\u20131398. doi: 10.1016\/j.febslet.2015.04.036","journal-title":"FEBS Lett"},{"issue":"1","key":"1_CR184","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13277-015-3769-4","volume":"37","author":"C Yoon","year":"2016","unstructured":"Yoon C, Kim J, Park G, Kim S, Kim D, Hur DY, Kim B, Kim YS (2016) Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt\u2019s lymphoma exosomes. Tumour Biol 37(1):313\u2013321. doi: 10.1007\/s13277-015-3769-4","journal-title":"Tumour Biol"},{"issue":"4","key":"1_CR185","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbrc.2013.03.022","volume":"433","author":"K Szenthe","year":"2013","unstructured":"Szenthe K, Koroknai A, Banati F, Bathori Z, Lozsa R, Burgyan J, Wolf H, Salamon D, Nagy K, Niller HH, Minarovits J (2013) The 5\u2032 regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells. Biochem Biophys Res Commun 433(4):489\u2013495. doi: 10.1016\/j.bbrc.2013.03.022","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR186","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.virol.2016.04.005","volume":"494","author":"Q Yin","year":"2016","unstructured":"Yin Q, Wang X, Roberts C, Flemington EK, Lasky JA (2016) Methylation status and AP1 elements are involved in EBV-mediated miR-155 expression in EBV positive lymphoma cells. Virology 494:158\u2013167. doi: 10.1016\/j.virol.2016.04.005","journal-title":"Virology"},{"issue":"7","key":"1_CR187","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1128\/JVI.02830-15","volume":"90","author":"Z Lin","year":"2016","unstructured":"Lin Z, Swan K, Zhang X, Cao S, Brett Z, Drury S, Strong MJ, Fewell C, Puetter A, Wang X, Ferris M, Sullivan DE, Li L, Flemington EK (2016) Secreted oral epithelial cell membrane vesicles induce Epstein-Barr virus reactivation in latently infected B cells. J Virol 90(7):3469\u20133479. doi: 10.1128\/JVI.02830-15","journal-title":"J Virol"},{"key":"1_CR188","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-3-319-22834-1_15","volume":"391","author":"S Gottschalk","year":"2015","unstructured":"Gottschalk S, Rooney CM (2015) Adoptive T-cell immunotherapy. Curr Top Microbiol Immunol 391:427\u2013454. doi: 10.1007\/978-3-319-22834-1_15","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"1_CR189","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.20040890","volume":"200","author":"CM Bollard","year":"2004","unstructured":"Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE (2004) Cytotoxic T lymphocyte therapy for Epstein-Barr virus + Hodgkin\u2019s disease. J Exp Med 200(12):1623\u20131633. doi: 10.1084\/jem.20040890","journal-title":"J Exp Med"},{"issue":"8","key":"1_CR190","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","volume":"110","author":"CM Bollard","year":"2007","unstructured":"Bollard CM, Gottschalk S, Leen AM, Weiss H, Straathof KC, Carrum G, Khalil M, Wu MF, Huls MH, Chang CC, Gresik MV, Gee AP, Brenner MK, Rooney CM, Heslop HE (2007) Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 110(8):2838\u20132845. doi: 10.1182\/blood-2007-05-091280","journal-title":"Blood"},{"issue":"9","key":"1_CR191","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/CJI.0b013e3181f3cbf4","volume":"33","author":"CU Louis","year":"2010","unstructured":"Louis CU, Straathof K, Bollard CM, Ennamuri S, Gerken C, Lopez TT, Huls MH, Sheehan A, Wu MF, Liu H, Gee A, Brenner MK, Rooney CM, Heslop HE, Gottschalk S (2010) Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother 33(9):983\u2013990. doi: 10.1097\/CJI.0b013e3181f3cbf4","journal-title":"J Immunother"},{"issue":"1","key":"1_CR192","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/mt.2013.242","volume":"22","author":"WK Chia","year":"2014","unstructured":"Chia WK, Teo M, Wang WW, Lee B, Ang SF, Tai WM, Chee CL, Ng J, Kan R, Lim WT, Tan SH, Ong WS, Cheung YB, Tan EH, Connolly JE, Gottschalk S, Toh HC (2014) Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and\/or locally recurrent nasopharyngeal carcinoma. Mol Ther 22(1):132\u2013139. doi: 10.1038\/mt.2013.242","journal-title":"Mol Ther"},{"issue":"8","key":"1_CR193","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","volume":"32","author":"CM Bollard","year":"2014","unstructured":"Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y, Carrum G, Ramos C, Fayad L, Shpall EJ, Pro B, Liu H, Wu MF, Lee D, Sheehan AM, Zu Y, Gee AP, Brenner MK, Heslop HE, Rooney CM (2014) Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol 32(8):798\u2013808. doi: 10.1200\/JCO.2013.51.5304","journal-title":"J Clin Oncol"},{"issue":"R1","key":"1_CR194","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1093\/hmg\/ddv270","volume":"24","author":"T Manzo","year":"2015","unstructured":"Manzo T, Heslop HE, Rooney CM (2015) Antigen-specific T cell therapies for cancer. Hum Mol Genet 24(R1):R67\u2013R73. doi: 10.1093\/hmg\/ddv270","journal-title":"Hum Mol Genet"},{"issue":"12","key":"1_CR195","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1182\/blood-2004-08-3337","volume":"105","author":"G Dotti","year":"2005","unstructured":"Dotti G, Savoldo B, Pule M, Straathof KC, Biagi E, Yvon E, Vigouroux S, Brenner MK, Rooney CM (2005) Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood 105(12):4677\u20134684. doi: 10.1182\/blood-2004-08-3337","journal-title":"Blood"},{"issue":"5","key":"1_CR196","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/CJI.0b013e318177092b","volume":"31","author":"AE Foster","year":"2008","unstructured":"Foster AE, Dotti G, Lu A, Khalil M, Brenner MK, Heslop HE, Rooney CM, Bollard CM (2008) Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. J Immunother 31(5):500\u2013505. doi: 10.1097\/CJI.0b013e318177092b","journal-title":"J Immunother"},{"issue":"1","key":"1_CR197","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1158\/1078-0432.CCR-12-2143","volume":"19","author":"SK Perna","year":"2013","unstructured":"Perna SK, De Angelis B, Pagliara D, Hasan ST, Zhang L, Mahendravada A, Heslop HE, Brenner MK, Rooney CM, Dotti G, Savoldo B (2013) Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma. Clin Cancer Res 19(1):106\u2013117. doi: 10.1158\/1078-0432.CCR-12-2143","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1_CR198","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/mt.2014.47","volume":"22","author":"AM Leen","year":"2014","unstructured":"Leen AM, Sukumaran S, Watanabe N, Mohammed S, Keirnan J, Yanagisawa R, Anurathapan U, Rendon D, Heslop HE, Rooney CM, Brenner MK, Vera JF (2014) Reversal of tumor immune inhibition using a chimeric cytokine receptor. Mol Ther 22(6):1211\u20131220. doi: 10.1038\/mt.2014.47","journal-title":"Mol Ther"},{"issue":"2","key":"1_CR199","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.coi.2009.03.002","volume":"21","author":"SA Rosenberg","year":"2009","unstructured":"Rosenberg SA, Dudley ME (2009) Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21(2):233\u2013240. doi: 10.1016\/j.coi.2009.03.002","journal-title":"Curr Opin Immunol"},{"issue":"177","key":"1_CR200","doi-asserted-by":"publisher","first-page":"177ra138","DOI":"10.1126\/scitranslmed.3005930","volume":"5","author":"RJ Brentjens","year":"2013","unstructured":"Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, Borquez-Ojeda O, Qu J, Wasielewska T, He Q, Bernal Y, Rijo IV, Hedvat C, Kobos R, Curran K, Steinherz P, Jurcic J, Rosenblat T, Maslak P, Frattini M, Sadelain M (2013) CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med 5(177):177ra138. doi: 10.1126\/scitranslmed.3005930","journal-title":"Sci Transl Med"},{"issue":"16","key":"1_CR201","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH (2013) Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 368(16):1509\u20131518. doi: 10.1056\/NEJMoa1215134","journal-title":"N Engl J Med"},{"issue":"5","key":"1_CR202","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","volume":"115","author":"HE Heslop","year":"2010","unstructured":"Heslop HE, Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA, Bollard CM, Liu H, Wu MF, Rochester RJ, Amrolia PJ, Hurwitz JL, Brenner MK, Rooney CM (2010) Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115(5):925\u2013935. doi: 10.1182\/blood-2009-08-239186","journal-title":"Blood"},{"issue":"23","key":"1_CR203","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1182\/blood-2009-07-230482","volume":"114","author":"B Angelis De","year":"2009","unstructured":"De Angelis B, Dotti G, Quintarelli C, Huye LE, Zhang L, Zhang M, Pane F, Heslop HE, Brenner MK, Rooney CM, Savoldo B (2009) Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506). Blood 114(23):4784\u20134791. doi: 10.1182\/blood-2009-07-230482","journal-title":"Blood"},{"issue":"23","key":"1_CR204","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1182\/blood-2009-07-228387","volume":"114","author":"J Brewin","year":"2009","unstructured":"Brewin J, Mancao C, Straathof K, Karlsson H, Samarasinghe S, Amrolia PJ, Pule M (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 114(23):4792\u20134803. doi: 10.1182\/blood-2009-07-228387","journal-title":"Blood"},{"issue":"12","key":"1_CR205","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/mt.2011.179","volume":"19","author":"LE Huye","year":"2011","unstructured":"Huye LE, Nakazawa Y, Patel MP, Yvon E, Sun J, Savoldo B, Wilson MH, Dotti G, Rooney CM (2011) Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Mol Ther 19(12):2239\u20132248. doi: 10.1038\/mt.2011.179","journal-title":"Mol Ther"},{"issue":"16","key":"1_CR206","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1182\/blood-2014-01-553362","volume":"124","author":"I Ricciardelli","year":"2014","unstructured":"Ricciardelli I, Blundell MP, Brewin J, Thrasher A, Pule M, Amrolia PJ (2014) Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells. Blood 124(16):2514\u20132522. doi: 10.1182\/blood-2014-01-553362","journal-title":"Blood"},{"issue":"14","key":"1_CR207","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","volume":"115","author":"A Moosmann","year":"2010","unstructured":"Moosmann A, Bigalke I, Tischer J, Schirrmann L, Kasten J, Tippmer S, Leeping M, Prevalsek D, Jaeger G, Ledderose G, Mautner J, Hammerschmidt W, Schendel DJ, Kolb HJ (2010) Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood 115(14):2960\u20132970. doi: 10.1182\/blood-2009-08-236356","journal-title":"Blood"},{"issue":"1","key":"1_CR208","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","volume":"31","author":"V Icheva","year":"2013","unstructured":"Icheva V, Kayser S, Wolff D, Tuve S, Kyzirakos C, Bethge W, Greil J, Albert MH, Schwinger W, Nathrath M, Schumm M, Stevanovic S, Handgretinger R, Lang P, Feuchtinger T (2013) Adoptive transfer of Epstein-Barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J Clin Oncol 31(1):39\u201348. doi: 10.1200\/JCO.2011.39.8495","journal-title":"J Clin Oncol"},{"issue":"11","key":"1_CR209","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/mt.2013.151","volume":"21","author":"U Gerdemann","year":"2013","unstructured":"Gerdemann U, Katari UL, Papadopoulou A, Keirnan JM, Craddock JA, Liu H, Martinez CA, Kennedy-Nasser A, Leung KS, Gottschalk SM, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM (2013) Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther 21(11):2113\u20132121. doi: 10.1038\/mt.2013.151","journal-title":"Mol Ther"},{"issue":"4","key":"1_CR210","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","volume":"110","author":"T Haque","year":"2007","unstructured":"Haque T, Wilkie GM, Jones MM, Higgins CD, Urquhart G, Wingate P, Burns D, McAulay K, Turner M, Bellamy C, Amlot PL, Kelly D, MacGilchrist A, Gandhi MK, Swerdlow AJ, Crawford DH (2007) Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 110(4):1123\u20131131. doi: 10.1182\/blood-2006-12-063008","journal-title":"Blood"},{"issue":"11","key":"1_CR211","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","volume":"119","author":"E Doubrovina","year":"2012","unstructured":"Doubrovina E, Oflaz-Sozmen B, Prockop SE, Kernan NA, Abramson S, Teruya-Feldstein J, Hedvat C, Chou JF, Heller G, Barker JN, Boulad F, Castro-Malaspina H, George D, Jakubowski A, Koehne G, Papadopoulos EB, Scaradavou A, Small TN, Khalaf R, Young JW, O\u2019Reilly RJ (2012) Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 119(11):2644\u20132656. doi: 10.1182\/blood-2011-08-371971","journal-title":"Blood"},{"issue":"26","key":"1_CR212","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","volume":"121","author":"AM Leen","year":"2013","unstructured":"Leen AM, Bollard CM, Mendizabal AM, Shpall EJ, Szabolcs P, Antin JH, Kapoor N, Pai SY, Rowley SD, Kebriaei P, Dey BR, Grilley BJ, Gee AP, Brenner MK, Rooney CM, Heslop HE (2013) Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 121(26):5113\u20135123. doi: 10.1182\/blood-2013-02-486324","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","Epstein Barr Virus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6655-4_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T12:16:40Z","timestamp":1601209000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6655-4_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"ISBN":["9781493966530","9781493966554"],"references-count":212,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6655-4_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]},"assertion":[{"value":"22 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}